메뉴 건너뛰기




Volumn 7, Issue 6, 2001, Pages 1023-1025

Vancomycin-intermediate Staphylococcus aureus in a home health-care patient

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTETAN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; ERYTHROMYCIN; FLUCONAZOLE; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; METRONIDAZOLE; OXACILLIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

EID: 0035202233     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0706.010618     Document Type: Article
Times cited : (42)

References (10)
  • 2
    • 0031564788 scopus 로고    scopus 로고
    • Reduced susceptiility of Staphylococcus aureus to vancomycin - Japan, 1996
    • (1997) MMWR Morb Mortal Wkly Rep , vol.46 , pp. 624-626
  • 3
    • 0034614298 scopus 로고    scopus 로고
    • Staphylococcusaureus with reduced susceptibility to vancomycin - Illinois, 1999
    • (2000) MMWR Morb Mortal Wkly Rep , vol.48 , pp. 1165-1167
  • 5
    • 0006379173 scopus 로고    scopus 로고
    • Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin
    • (1997) MMWR Morb Moral Wkly Rep , vol.46 , pp. 626-635
  • 10
    • 0035133008 scopus 로고    scopus 로고
    • Vancomycin-intermediate and -resistant Staphylooccus aureus: What the infectious disease specialist needs to know
    • (2001) Clin Infect Dis , vol.32 , pp. 108-115
    • Fridkin, S.K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.